BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12538879)

  • 21. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.
    Becker TM; Rizos H; Kefford RF; Mann GJ
    Clin Cancer Res; 2001 Oct; 7(10):3282-8. PubMed ID: 11595726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells.
    Rizos H; Darmanian AP; Indsto JO; Shannon JA; Kefford RF; Mann GJ
    Melanoma Res; 1999 Feb; 9(1):10-9. PubMed ID: 10338330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent patterns of dual RB and p53 pathway inactivation in melanoma.
    Yang G; Rajadurai A; Tsao H
    J Invest Dermatol; 2005 Dec; 125(6):1242-51. PubMed ID: 16354195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J; Wei T; Lahti JM; Kidd VJ
    Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
    Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
    Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis.
    Ferguson B; Konrad Muller H; Handoko HY; Khosrotehrani K; Beermann F; Hacker E; Soyer HP; Bosenberg M; Walker GJ
    Pigment Cell Melanoma Res; 2010 Dec; 23(6):771-80. PubMed ID: 20718941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
    Williams RT; Barnhill LM; Kuo HH; Lin WD; Batova A; Yu AL; Diccianni MB
    PLoS One; 2014; 9(2):e88219. PubMed ID: 24505435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
    Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
    Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
    Schmidt M; Fan Z
    Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo.
    Fujita M; Norris DA; Yagi H; Walsh P; Morelli JG; Weston WL; Terada N; Bennion SD; Robinson W; Lemon M; Maxwell IH; Yohn JJ
    Melanoma Res; 1999 Jun; 9(3):279-91. PubMed ID: 10465584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
    Recio JA; Noonan FP; Takayama H; Anver MR; Duray P; Rush WL; Lindner G; De Fabo EC; DePinho RA; Merlino G
    Cancer Res; 2002 Nov; 62(22):6724-30. PubMed ID: 12438273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.
    Lu Y; Lian H; Sharma P; Schreiber-Agus N; Russell RG; Chin L; van der Horst GT; Bregman DB
    Mol Cell Biol; 2001 Mar; 21(5):1810-8. PubMed ID: 11238917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent p16-independent inactivation of p14ARF in human melanoma.
    Freedberg DE; Rigas SH; Russak J; Gai W; Kaplow M; Osman I; Turner F; Randerson-Moor JA; Houghton A; Busam K; Timothy Bishop D; Bastian BC; Newton-Bishop JA; Polsky D
    J Natl Cancer Inst; 2008 Jun; 100(11):784-95. PubMed ID: 18505964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.
    Yang G; Curley D; Bosenberg MW; Tsao H
    Cancer Res; 2007 Jun; 67(12):5649-57. PubMed ID: 17575131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human melanocyte senescence and melanoma susceptibility genes.
    Bennett DC
    Oncogene; 2003 May; 22(20):3063-9. PubMed ID: 12789281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
    Al-Khalaf HH; Hendrayani SF; Aboussekhra A
    Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.